Copyright
©The Author(s) 2022.
World J Cardiol. Jul 26, 2022; 14(7): 411-426
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.411
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.411
Model 1 | Model 2 | |||||
HR | (95%CI) | P value | HR | (95%CI) | P value | |
Ref to 25(OH)D ≥ 30 ng/dL | ||||||
25(OH)D for HD | ||||||
20-29 | 1.13 | (0.82-1.55) | 0.45 | 1.13 | (0.83-1.52) | 0.43 |
< 20 | 1.54 | (1.14-2.08) | 0.005 | 1.43 | (1.07-1.91) | 0.017 |
25(OH)D for CBVD | ||||||
20-29 | 0.97 | (0.61-1.53) | 0.88 | 0.98 | (0.62-1.56) | 0.94 |
< 20 | 1.15 | (0.58-2.26) | 0.69 | 1.14 | (0.58-2.25) | 0.69 |
25(OH)D for CVD | ||||||
20-29 | 1.09 | (0.82-1.46) | 0.54 | 1.10 | (0.82-1.46) | 0.52 |
< 20 | 1.44 | (1.09-1.91) | 0.011 | 1.36 | (1.04-1.78) | 0.028 |
25(OH)D for all-cause mortality | ||||||
20-29 | 1.16 | (0.99-1.35) | 0.06 | 1.16 | (0.99-1.36) | 0.07 |
< 20 | 1.38 | (1.16-1.64) | 0.001 | 1.32 | (1.10-1.58) | 0.004 |
Ref to Non-MetS | ||||||
MetS for HD | 1.31 | (1.09-1.58) | 0.005 | 1.22 | (1.00-1.49) | 0.053 |
MetS for CBVD | 1.58 | (0.94-2.66) | 0.083 | 1.60 | (0.96-2.65) | 0.069 |
MetS for CVD | 1.37 | (1.12-1.66) | 0.002 | 1.29 | (1.05-1.59) | 0.017 |
MetS for all-cause mortality | 1.22 | (1.08-1.37) | 0.002 | 1.20 | (1.05-1.36) | 0.008 |
Interaction of | ||||||
25(OH)D x MetS on | ||||||
HD | 0.91 | (0.72-1.17) | 0.46 | 0.91 | (0.72-1.15) | 0.41 |
CBVD | 0.80 | (0.39-1.66) | 0.54 | 0.79 | (0.38-1.62) | 0.50 |
CVD | 0.89 | (0.71-1.12) | 0.31 | 0.88 | (0.70-1.11) | 0.28 |
All-cause | 0.98 | (0.84-1.14) | 0.78 | 0.96 | (0.82-1.13) | 0.63 |
- Citation: Liu L, Cui S, Volpe SL, May NS, Sukumar D, DiMaria-Ghalili RA, Eisen HJ. Vitamin d deficiency and metabolic syndrome: The joint effect on cardiovascular and all-cause mortality in the United States adults . World J Cardiol 2022; 14(7): 411-426
- URL: https://www.wjgnet.com/1949-8462/full/v14/i7/411.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i7.411